MNIVF (Monash IVF Group) Defensive Interval Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MNIVF Monash IVF Group Ltd MNIVF
77 GF Score
Price $0.40
GF Value $0.61
! 10 Warning Signs
View Full Analysis

What is Monash IVF Group Defensive Interval Ratio?

MNIVF
77GF Score
Monash IVF Group Ltd MNIVF
Defensive Interval Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Monash IVF Group (MNIVF) Overvalued in 2026?

Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued. The current stock price of $0.40 is trading 34.4% below its estimated GF Value™ of $0.61.

Key valuation signals for MNIVF:

  • Defensive Interval Ratio:
  • GF Value™: $0.61 vs. price of $0.40 (34.4% below fair value)
  • GF Score™: 77/100 with 10 warning signs

No single metric tells the full story. See the MNIVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Monash IVF Group Business Description

Other Exchanges MVF:Australia
Address 510 Church Street, Level 1, Cremorne, VIC, AUS, 3121
Monash IVF Group Ltd is an Australian provider of assisted reproductive services and prenatal diagnostics. The company operates fertility clinics, ultrasound practices, and diagnostic genetics services across Australia and, to a lesser extent, Southeast Asia. Its core business covers in vitro fertilisation (IVF), fertility preservation, egg and sperm freezing, andrology, and genetic testing, alongside obstetric and gynaecological ultrasound through its Monash Ultrasound for Women network. Brands and operations include Monash IVF, Repromed, and KL Fertility in Malaysia. Revenue is generated primarily from patient fees for fertility treatment cycles, diagnostic procedures, and related services, with the majority derived from its Australian IVF and ultrasound operations. The company serves individuals and couples seeking fertility treatment, as well as patients requiring prenatal and genetic diagnostics, and maintains relationships with referring specialists and healthcare providers.
77GF Score

Get the complete analysis for MNIVF

Defensive Interval Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.40
Price
$0.61
GF Value